BioCryst Pharmaceuticals,Inc. (BCRX)

[agribusiness72]

Every quarter. May have an update with 10K, but not financial numbers as insurance payments probably won't hit the books until Jan. 1st major update expected with 1st qtr report. Expect Japan approval next week with spike to $10.00 per. UK approval by end of March, though the UK has approved Orladeyo for use prior to official approval. See my previous post for link.

More interesting though will be their updates on their Factor D. My sell point is $120.00. Expected in 2023.